Latest Insider Transactions at Patterson Companies, Inc. (PDCO)
This section provides a real-time view of insider transactions for Patterson Companies, Inc. (PDCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PATTERSON COMPANIES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PATTERSON COMPANIES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 12
2024
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-0.59%
|
$18,780
$20.76 P/Share
|
Nov 12
2024
|
Les B Korsh CLO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-1.01%
|
$21,040
$20.76 P/Share
|
Sep 30
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.04%
|
$162
$18.56 P/Share
|
Sep 16
2024
|
Pamela J Tomczik |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+50.0%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Neil A Schrimsher |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+13.81%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Philip Mc Koy |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+30.15%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Robert Frenzel |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+16.98%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Jody H Feragen |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+12.04%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
John D Buck |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+7.77%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Alex N Blanco |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+15.92%
|
$164,220
$21.74 P/Share
|
Sep 16
2024
|
Meenu Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+37.95%
|
$164,220
$21.74 P/Share
|
Jul 16
2024
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
7,216
-3.04%
|
$173,184
$24.99 P/Share
|
Jul 03
2024
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
2,842
-2.67%
|
$65,366
$23.71 P/Share
|
Jul 03
2024
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
5,875
-2.42%
|
$135,125
$23.71 P/Share
|
Jul 03
2024
|
Kevin Michael Barry CFO |
SELL
Open market or private sale
|
Direct |
1,216
-2.84%
|
$27,968
$23.72 P/Share
|
Jul 03
2024
|
Samantha L Bergeson CHRO |
SELL
Open market or private sale
|
Direct |
254
-1.22%
|
$5,842
$23.87 P/Share
|
Jul 01
2024
|
Donald Zurbay President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,450
+18.7%
|
$2,650,800
$24.08 P/Share
|
Jul 01
2024
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,210
-3.11%
|
$221,040
$24.08 P/Share
|
Jul 01
2024
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,133
+11.11%
|
$939,192
$24.08 P/Share
|
Jul 01
2024
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,915
-1.15%
|
$69,960
$24.08 P/Share
|
Jul 01
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+30.97%
|
$224,256
$24.08 P/Share
|
Jul 01
2024
|
Samantha L Bergeson CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
571
-4.74%
|
$13,704
$24.08 P/Share
|
Jul 01
2024
|
Les B Korsh CLO & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
32,238
+13.48%
|
$773,712
$24.08 P/Share
|
Jul 01
2024
|
Les B Korsh CLO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,726
-2.29%
|
$89,424
$24.08 P/Share
|
Jul 01
2024
|
Kevin Michael Barry CFO |
BUY
Grant, award, or other acquisition
|
Direct |
23,054
+21.83%
|
$553,296
$24.08 P/Share
|
Jul 01
2024
|
Kevin Michael Barry CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-4.16%
|
$45,768
$24.08 P/Share
|
Jun 30
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
427
+3.42%
|
$8,540
$20.5 P/Share
|
Mar 31
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
436
+3.61%
|
$10,028
$23.5 P/Share
|
Dec 19
2023
|
Kevin Michael Barry CFO |
SELL
Open market or private sale
|
Direct |
560
-2.52%
|
$15,120
$27.18 P/Share
|
Dec 15
2023
|
Kevin Michael Barry CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
869
-3.76%
|
$23,463
$27.0 P/Share
|
Dec 15
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
996
-0.81%
|
$26,892
$27.0 P/Share
|
Dec 06
2023
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
1,868
-1.3%
|
$48,568
$26.58 P/Share
|
Dec 05
2023
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,748
-3.84%
|
$149,448
$26.59 P/Share
|
Dec 01
2023
|
Kevin Michael Barry CFO |
SELL
Open market or private sale
|
Direct |
1,627
-6.58%
|
$40,675
$25.36 P/Share
|
Nov 14
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-0.43%
|
$17,216
$32.02 P/Share
|
Oct 05
2023
|
Timothy E Rogan President - Dental |
SELL
Open market or private sale
|
Direct |
9,260
-18.65%
|
$268,540
$29.75 P/Share
|
Sep 30
2023
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
422
+3.63%
|
$9,706
$23.69 P/Share
|
Sep 11
2023
|
Robert Frenzel |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+14.04%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Philip Mc Koy |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+32.55%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Ellen A Rudnick Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+6.16%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Neil A Schrimsher |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+10.82%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Meenu Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+50.0%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Alex N Blanco |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+12.92%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
John D Buck |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+5.52%
|
$144,072
$29.19 P/Share
|
Sep 11
2023
|
Jody H Feragen |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+9.15%
|
$144,072
$29.19 P/Share
|
Jul 19
2023
|
Timothy E Rogan President - Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.84%
|
$24,320
$32.46 P/Share
|
Jul 18
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
3,686
-4.51%
|
$117,952
$32.47 P/Share
|
Jul 18
2023
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
5,620
-3.62%
|
$179,840
$32.48 P/Share
|
Jul 14
2023
|
Kevin Michael Barry CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,160
-4.32%
|
$69,120
$32.07 P/Share
|
Jul 14
2023
|
Kevin Michael Barry CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,501
+17.25%
|
$176,032
$32.07 P/Share
|